Financhill
Back

Seelos Therapeutics Quote, Financials, Valuation and Earnings

Invest in This AI Tech Innovator Doubling Revenue

Invest Now!
Sell
44

SEEL
Seelos Therapeutics

Last Price:
3.95
Seasonality Move:
3.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest in the Next Big AI Disruptor Today

Learn More

Seelos Therapeutics Price Quote

$3.95
+0.05 (+-20.95%)
(Updated: September 28, 2024 at 6:59 AM ET)

Seelos Therapeutics Key Stats

Sell
44
Seelos Therapeutics (SEEL) is a Sell

Day range:
$3.71 - $4.57
52-week range:
$2.90 - $848.64
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.07
P/B ratio:
0%

Volume:
1.3M
Avg. volume:
999.1K
1-year change:
-99.5%
Market cap:
$1.7M
Revenue:
$0
EPS:
$-475.52

How Much Does Seelos Therapeutics Make?

Data Unavailable

Is Seelos Therapeutics Growing As A Company?

Data Unavailable

Seelos Therapeutics Stock Price Performance

What Is Seelos Therapeutics 52-Week High & Low?

Seelos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Seelos Therapeutics?

Is Seelos Therapeutics Cash Flow Positive?

  • What Is SEEL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.3M
  • What Is Seelos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.7M
  • What Is Seelos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Seelos Therapeutics Return On Invested Capital

Data Unavailable

Seelos Therapeutics Earnings Date & Stock Price

Seelos Therapeutics Competitors

Seelos Therapeutics Dividend Yield

Seelos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 512.00
Upside from Last Price: 13028.21%

Major Shareholders

  • How many SEEL shares are owned by institutional investors?
    740.8K SEEL shares are owned by institutional investors
  • How many SEEL shares are owned by insiders?
    12.7M SEEL shares are owned by insiders